Medikaloka Hermina Pt Stock Probability Of Bankruptcy
| HEAL Stock | IDR 1,335 18.50 1.41% |
Medikaloka |
Medikaloka Hermina PT Company odds of financial distress Analysis
Medikaloka Hermina's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Medikaloka Hermina Probability Of Bankruptcy | Less than 9% |
Most of Medikaloka Hermina's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medikaloka Hermina PT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Medikaloka Hermina probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Medikaloka Hermina odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Medikaloka Hermina PT financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Medikaloka Hermina PT has a Probability Of Bankruptcy of 9.0%. This is 79.21% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all Indonesia stocks is 77.4% higher than that of the company.
Medikaloka Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medikaloka Hermina's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medikaloka Hermina could also be used in its relative valuation, which is a method of valuing Medikaloka Hermina by comparing valuation metrics of similar companies.Medikaloka Hermina is currently under evaluation in probability of bankruptcy category among related companies.
Medikaloka Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 23.44 T | |||
| Shares Outstanding | 14.48 B | |||
| Shares Owned By Insiders | 51.07 % | |||
| Shares Owned By Institutions | 7.10 % | |||
| Price To Earning | 7.42 X | |||
| Price To Book | 6.72 X | |||
| Price To Sales | 4.66 X | |||
| Revenue | 5.82 T | |||
| Gross Profit | 2.71 T | |||
| EBITDA | 1.9 T | |||
| Net Income | 1 T | |||
| Cash And Equivalents | 590.19 B | |||
| Cash Per Share | 40.20 X | |||
| Total Debt | 1.47 T | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 1.59 X | |||
| Book Value Per Share | 230.87 X | |||
| Cash Flow From Operations | 1.86 T | |||
| Earnings Per Share | 32.62 X | |||
| Target Price | 1693.1 | |||
| Number Of Employees | 14.38 K | |||
| Beta | 0.4 | |||
| Market Capitalization | 22.15 T | |||
| Total Asset | 7.59 T | |||
| Z Score | 9.0 | |||
| Annual Yield | 0 % | |||
| Net Asset | 7.59 T | |||
| Last Dividend Paid | 6.0 |
About Medikaloka Hermina Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medikaloka Hermina PT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medikaloka Hermina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medikaloka Hermina PT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Medikaloka Hermina using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Medikaloka Hermina PT. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Medikaloka Stock analysis
When running Medikaloka Hermina's price analysis, check to measure Medikaloka Hermina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medikaloka Hermina is operating at the current time. Most of Medikaloka Hermina's value examination focuses on studying past and present price action to predict the probability of Medikaloka Hermina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medikaloka Hermina's price. Additionally, you may evaluate how the addition of Medikaloka Hermina to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |